The necessity for auto injector has been growing rapidly over the years, spurring a variety of innovative designs to meet patient needs and to differentiate amongst the industry.
When designing an auto injector, SHL’s industrial design team focuses on being simplistic and minimalist without sacrificing user-convenience and safety. A user-centric design process led to the development of various auto injectors such as the Emerade® Adrenaline Auto Injector and the Amber® Auto Injector. OnDrugDelivery’s May 2015 issue recently featured an article on SHL’s “User-centric Approach to the Design & Development of Auto Injectors,” an interview article with Jochten Ratjen, Director of Industrial Design at SHL, who shares his team’s methods of approach to designing auto injectors with a human touch.
The questions address some key concepts such as industrial design considerations, importance of HFE (Human Factors Engineering), balancing customer URS (User Requirement Specifications) and the ideal User-Centric design, source of innovation, upcoming trend of auto injectors and more.
A: DFM was in fact one of the main reasons SHL took the strategic decision to establish an in-house design department 14 years ago. This enabled close collaboration and instant communication between industrial design engineers, production teams and project managers. The result is a faster track towards a finalised product for mass production. Today, one of the valuable products SHL offers is the in-house availability of...
SHL is one of the world’s largest solution providers in design, development and manufacturing of advanced drug delivery devices such as auto injectors and pen injectors. With locations in Taiwan, Sweden and the US, our experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
With over 3,500 staff worldwide, our organization consists of several distinct group companies:
SHL Medical Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies
SHL Healthcare Develops and manufactures equipment solutions for home, hospital and long term care use
SHL Technologies Provides contract manufacturing and engineering services for the production of complex medtech and industrial products
For additional information visit www.shl-group.com or contact us at email@example.com